These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 693562)

  • 21. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test.
    Moss DE; Johnson RL
    Eur J Pharmacol; 1980 Feb; 61(3):313-5. PubMed ID: 6244965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The suppressive effect of delta-1-tetrahydrocannabinol on the steroidogenic activity of rat granulosa cells in culture.
    Lewysohn O; Cordova T; Nimrod A; Ayalon D
    Horm Res; 1984; 19(1):43-51. PubMed ID: 6319259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region.
    Schmeling WT; Hosko MJ
    Pharmacol Biochem Behav; 1976 Jul; 5(1):79-83. PubMed ID: 996043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses to oral delta9-tetrahydrocannabinol in frequent and infrequent marijuana users.
    Kirk JM; de Wit H
    Pharmacol Biochem Behav; 1999 May; 63(1):137-42. PubMed ID: 10340534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
    Gorriti MA; Rodríguez de Fonseca F; Navarro M; Palomo T
    Eur J Pharmacol; 1999 Jan; 365(2-3):133-42. PubMed ID: 9988095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisense oligodeoxynucleotides to the kappa1 receptor enhance delta9-THC-induced antinociceptive tolerance.
    Rowen DW; Embrey JP; Moore CH; Welch SP
    Pharmacol Biochem Behav; 1998 Feb; 59(2):399-404. PubMed ID: 9476987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marihuana inhibits dihydrotestosterone binding to the androgen receptor.
    Purohit V; Ahluwahlia BS; Vigersky RA
    Endocrinology; 1980 Sep; 107(3):848-50. PubMed ID: 6249575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
    Singh AK; Zeleznikar RJ; Drewes LR
    Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.
    Malone DT; Taylor DA
    Behav Brain Res; 2006 Jan; 166(1):101-9. PubMed ID: 16143410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of delta-9-tetrahydrocannabinol on uterine and vaginal cytology of ovariectomized rats.
    Solomon J; Cocchia MA; DiMartino R
    Science; 1977 Mar; 195(4281):875-7. PubMed ID: 841311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.